400: Seaport's IPO adventure, obesity pill battles, and Makary's troubles

On this week’s episode of "The Readout LOUD," we chat with Seaport Therapeutics CEO Daphne Zohar, fresh off the biotech’s successful IPO. Plus, Elaine, Allison, and Adam chat about this week’s notable news, including the obesity pill battle between Eli Lilly and Novo Nordisk, a Phase 3 study win for Cytokinetics, and FDA Commissioner Marty Makary’s White House troubles. Oh, by the way, this is the 400th episode of your favorite biotech podcast.

Episode metadata supplied by the publisher feed · Published May 7, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

400: Seaport's IPO adventure, obesity pill battles, and Makary's troubles

0:00 33:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 33 minutes long.

When was this The Readout Loud episode published?

This episode was published on May 7, 2026.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!